Hedge funds and other institutional investors have recently made changes to their positions in the business. Ameritas Investment Partners Inc. purchased a new stake in shares of Eton Pharmaceuticals in the second quarter valued at $37,000. Legal & General Group Plc purchased a new stake in shares of Eton Pharmaceuticals in the second quarter valued at $41,000. AlphaQuest LLC purchased a new stake in shares of Eton Pharmaceuticals in the first quarter valued at $53,000. Police & Firemen s Retirement System of New Jersey purchased a new stake in shares of Eton Pharmaceuticals in the second quarter valued at $87,000. Finally, Tower Research Capital LLC TRC purchased a new stake in shares of Eton Pharmaceuticals in the fourth quarter valued at $86,000. Hedge funds and other institutional investors own 27.86% of the company's stock.